Popular Articles
Cellulite Cream

Abbott Initiates Trial Of Next-Generation XIENCE PRIME(TM) Drug Eluting Stent, Building Upon Superior Outcomes From SPIRIT Family Of Trials
Abbott (NYSE: ABT) announced the initiation of SPIRIT PRIME, a clinical trial to study the performance of the company"s next-generation XIENCE PRIME(TM) Everolimus Eluting Coronary Stent System, currently an investigational device, for the treatment of coronary artery disease. Results from SPIRIT PRIME will be used to support the regulatory filing for XIENCE PRIME in the United States. The first patient was enrolled into the SPIRIT PRIME clinical trial at Hillcrest Medical Center in Tulsa, Okla., by Rajesh Chandwaney, M.D.
generic viagra online
Lancet Studies Examine Aspects Of Global Health Funding
"Global health funding boosted by private donors has quadrupled since 1990, but the extra money has not always gone to the right countries and diseases, according to a pair of studies released Friday," in the journal Lancet, AFP/Google.com reports (Hood, AFP/Google.com, 6/18).
News of the day
Research Shows Temptation More Powerful Than Individuals Realize
Whether it"s highlighted in major news headlines about Argentinean affairs and Ponzi schemes, or in personal battles with obesity and drug addiction, individuals regularly succumb to greed, lust and self-destructive behaviors. New research from the Kellogg School of Management examines why this is the case, and demonstrates that individuals believe they have more restraint than they actually possess - ultimately leading to poor decision-making.
Sexual Health

In A Rare Disorder, A Familiar Protein Disrupts Gene Function

As reported this week in the open-access journal PLoS Biology, an international team of scientists studying a rare genetic disease has discovered that a bundle of proteins already known to be important for keeping chromosomes together also plays an important role in regulating gene expression in humans. In addition to shedding light on the biological roles of these proteins, the research may lead to the development of better diagnostic tools for Cornelia de Lange syndrome (CdLS), a multisystem developmental disease. Ian D. Krantz, of The Children"s Hospital of Philadelphia, and colleagues investigated cohesin, a protein complex consisting of at least four proteins that form a ring that encircles chromosomes during cell division. Cohesin"s long-established "canonical" role is to control chromatids-the long strands that chromosomes form during DNA replication. However, one open question in biology has been, "What does cohesin do when cells are not dividing?" The paper from Krantz"s team provides part of the answer, as the first study in human cells to identify genes that are dysregulated when cohesin doesn"t work properly. Cohesin"s role in dysregulating gene expression has attracted considerable scientific interest with a recent discovery that it may also be implicated in cancer. Using DNA microarrays, Krantz and colleagues did a genome-wide analysis of mutant cell lines from 16 patients with severe CdLS. All the cells had mutations in the NIPBL gene, which plays a role in moving cohesin onto and off chromosomes, or in genes encoding components of the cohesin complex itself. The study team identified hundreds of genes that were dysregulated in patient samples compared to samples from healthy individuals, and also detected specific gene expression profiles that are unique to CdLS patients. Importantly, said Krantz, the expression levels of dysregulated genes corresponded to the severity of the disease. "We found that gene expression is exquisitely regulated by cohesin and the NIBPL gene," said Krantz. "The gene expression patterns we found have great potential to be used in a diagnostic tool for Cornelia de Lange syndrome." He added that gene profiling arrays have the potential to be developed as single-platform tools to diagnose, from a patient"s blood sample, not only CdLS, but also a variety of other developmental disorders. Funding: JL is supported by a CdLS Foundation Fellowship Grant; IDK is supported by PO1 HD052860, NICHD; KS was supported in part by a grant of the Genome Network Project and Grant-in-Aid for Scientific Research (S) from the MEXT, Japan. MAD. is supported by KO8 HD055488, NICHD. This project is funded, in part, under a grant with the Pennsylvania Department of Health (to NBS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing interests statement: The authors declare that no competing interests exist. Citation: "Transcriptional Dysregulation in NIPBL and Cohesin Mutant Human Cells." Liu J, Zhang Z, Bando M, Itoh T, Deardorff MA, et al. (2009) PLoS Biol 7(5):e1000119. doi:10.1371/journal.pbio.1000119 Plos Biology


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):